Blog — PSA
Mastering Male Health: Unveiling the Significance of Blood Profiles I & II
Publié par Behcet Bicakci le
Understanding the intricate balance of hormones is crucial in the journey towards optimal health, especially for men. ZRT Laboratories introduces two comprehensive Dried Blood Spot (DBS) profiles, Male Blood Profiles I & II, designed to provide valuable insights into sex hormones, adrenal function, and thyroid health. In this blog, we'll delve into the components of each profile, their significance, and the considerations they address for men seeking a thorough hormonal assessment. Deciphering Male Blood Profile I: Tailored for men, Male Blood Profile I stands as a robust tool for assessing sex and adrenal hormone levels, with an added PSA test...
Prostate-Specific Antigen (PSA) Testing in Dried Blood Spot: Convenient and Beneficial
Publié par Behcet Bicakci le
Regular health check-ups are crucial for maintaining overall well-being, and when it comes to men's health, monitoring prostate health is of utmost importance. The Prostate-Specific Antigen (PSA) Test has long been used to assess prostate health and detect potential issues such as benign prostatic hyperplasia (BPH) or prostate cancer. With advancements in medical technology, a convenient and effective method of conducting this test has emerged: dried blood spot testing. In this blog post, we will explore the symptoms that may indicate the need for a PSA test, the benefits of using dried blood spot testing, and how the process works....
Prostate Cancer Prevention – Identifying Areas of Susceptibility
Publié par Ben White le
In our current medical paradigm, screening for cancer is considered a preventive measure by virtue of providing an earlier diagnosis. Getting an early jump on a disease process like cancer makes treatment exponentially easier and outcomes generally better. Under the current guidelines, that early jump on prostate cancer starts at age 55 for men at low to moderate risk and 40-45 for men at high risk. It takes years for cancer to grow to a detectable point after the tumor's initial induction from a normal cell to a cancerous one. There's been a lot of research done to determine what...